Physician profile
Jane Smith
NPI 1861647505
$1,240.17
in general payments reported to CMS, 2019-2025
11 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $34.89 · 2023: $418 · 2024: $454 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967 · Education: $49.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.49 |
| Education | $49.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $378.65 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Regeneron Healthcare Solutions, INC. | $283.85 | 2021-2024 | Dupixent |
| Genzyme Corporation | $152.16 | 2023-2025 | |
| Genentech USA, INC. | $92.16 | 2024 | Xolair |
| Blueprint Medicines Corporation | $85.13 | 2023 | Ayvakit |
| Glaxosmithkline, LLC. | $70.34 | 2023-2025 | Nucala, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $63.43 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.51 | 2022-2025 | Takhzyro, Eohilia |
| Csl Behring | $40.46 | 2023-2025 | Hizentra, Haegarda |
| Grifols USA, LLC | $15.72 | 2023 | Xembify |
| Amgen INC. | $12.76 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.